Mankind Pharma IPO: Apply or Avoid? | Mankind Pharma IPO | Share Market | Jagran Business

Mankind Pharma's IPO received 14% of its total subscriptions on Day 1. While just 10% of regular investors subscribed, 33% of non-institutional investors (NIIs) did. However, just 8% of subscribers chose the QIB category. Grey market premium (GMP) for Mankind Pharma is reportedly greater on Tuesday than it was on Monday, according to market sources.

The public may place a bid on the Rs 4,300 crore IPO, which is entirely an OFS, through April 27. Investors may make bids for 13 shares in a single lot and multiples of that.About 40 million shares will be sold by promoters and selling stockholders under the OFS. The price range the corporation has established for shares is ₹. 1,026–$1080.